Skip to main content

Table 3 Governments in the WHO European Region reporting activities addressing viral hepatitis by WHO Global Hepatitis Programme strategic axis (N=44)

From: Policy responses to viral hepatitis B and C among people who inject drugs in Member States of the WHO European region: a sub-analysis of the WHO 2013 global hepatitis policy survey

  

N=44 n (%)

Member States Reporting Activities

National Coordination

Have viral hepatitis programme activities targeting PWID as a specific population

32 (73)

Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, Finland, France, Ireland, Israel, Italy, Kyrgyzstan, Latvia, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom

 

Have a written national viral hepatitis prevention and control strategy or plan which includes a component relating to injection drug use

12 (27)

Armenia, Austria, Czech Republic, Denmark, France, Israel, Kyrgyzstan, Republic of Moldova, Russian Federation, Slovenia, Turkey, United Kingdom

Axis 1

Held events for World Hepatitis Day 2012

17 (39)

Albania, Armenia, Azerbaijan, Belarus, Bulgaria, Croatia, France, Georgia, Italy, Latvia, Lithuania, Malta, Netherlands, Republic of Moldova, Russian Federation , Slovenia, Sweden

 

Funded viral hepatitis awareness campaigns focusing on harm reduction for PWID (other than World Hepatitis Day)

10 (23)

Armenia, Belarus, Croatia, Netherlands, Republic of Moldova, Russian Federation, Slovenia, Sweden, Turkey, United Kingdom

Axis 2

Conduct regular serosurveys among PWID

12 (27)

Belarus, Croatia, Denmark, Finland, France, Montenegro, Moldova, Russian Federation, Slovenia, Tajikistan, Ukraine, United Kingdom

Axis 3

Have a national policy for prevention of viral hepatitis among PWID

25 (53)

Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Czech Republic, Denmark, France, Israel, Italy, Kyrgyzstan, Luxembourg, Netherlands, Poland, Republic of Moldova, Russian Federation, Slovenia, Spain, Sweden, Switzerland, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom, Uzbekistan

Axis 4

Have HBV and HCV testing which is:

  
 

• Free of charge for all individuals

20 (45)

• Albania, Austria, Azerbaijan, Belarus, Belgium, Croatia, Denmark, Finland, France, Germany, Israel, Italy, Montenegro, Republic of Moldova, Malta, San Marino, Slovakia, Spain, Sweden, United Kingdom

 

• Free of charge for PWID

6 (14)

• Bulgaria, Czech Republic, Latvia, Slovenia Turkey, The Former Yugoslav Republic of Macedonia

 

Have publicly funded treatment for HBV

36 (82)

Andorra, Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovakia, Slovenia, Spain, Sweden, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom

 

Have publicly funded treatment for HCV

35 (80)

Andorra, Armenia, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Germany, Hungary, Ireland, Israel, Italy, Latvia, Lithuania, Luxembourg, Malta, Montenegro, Netherlands, Poland, Republic of Moldova, Russian Federation, San Marino, Serbia, Slovenia, Spain, Sweden, The Former Yugoslav Republic of Macedonia, Turkey, United Kingdom